Kr. Larsen et al., EFFECTS OF TOLCAPONE, A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, AND SINEMET ON INTESTINAL ELECTROLYTE AND FLUID TRANSPORT IN CONSCIOUS DOGS, Digestive diseases and sciences, 43(8), 1998, pp. 1806-1813
Tolcapone (T) is a novel catechol-O-methyltransferase (COMT) inhibitor
recently introduced for the treatment of Parkinson's disease. In clin
ical efficacy studies, T has been associated with a low incidence of d
iarrhea. The objectives of the study were to examine whether T and its
adjunctive drug Sinemet (S) could influence intestinal fluid and elec
trolyte transport as a possible cause for the diarrhea. The studies we
re conducted in conscious dogs surgically prepared with Thiry-Vella lo
ops constructed from a 40-cm jejunal segment. A physiologically buffer
ed test solution was perfused into the orad stoma and collected from t
he caudad stoma. Secretions were collected at 15-min intervals and ana
lyzed for volume, electrolytes, lipid phosphorus, and protein. The acu
te oral administration of T (10 and 30 mg/kg doses) was well tolerated
. Concurrent acute administration of S (25 mgikg) with T (30 mg/kg) wa
s also well tolerated. The acute oral administration of T induced a do
se-dependent efflux of intestinal fluid and electrolytes (sodium, pota
ssium, chloride, and bicarbonate) secretion (P < 0.05). The oral coadm
inistration of S (25 mg/kg) with T (30 mgikg) accelerated the onset of
the stimulation of intestinal secretion. Despite the significant stim
ulation of intestinal secretion, none of the dogs developed diarrhea,
indicating the importance of intestinal compensatory mechanisms. Neith
er T nor T&S affected calcium, lipid, or protein efflux rates, suggest
ing that the stimulated secretion was not a consequence of intestinal
mucosal injury. The chronic (seven-day) administration of T and T&S wa
s associated with reduced intestinal secretory responses when compared
with the acute administration of the same drugs S enhanced the T-indu
ced tolerance development. The basis for such tolerance is unknown. In
conclusion, the stimulatory systemic actions of tolcapone on intestin
al secretion may, under certain conditions, contribute to the inductio
n of diarrhea in susceptible patients.